BUDESONIDE 0.5mg. IP

An anti-asthmatic agent used for maintenance treatment and prophylactic therapy for patients with asthma. (Kalola & Ambati) A very potent glucocorticoid used in asthma and other airway diseases to decrease lung inflammation. (Noah H. Hillman, 2021) Effectively relieves asthma symptoms and improves pulmonary function in mild-to-severe persistent asthma. (Mellon, 1999) Produces significant improvements in nighttime/daytime symptoms and significant decreases in rescue medication use. (J P Kemp, 1999) Improves airflow obstruction in patients with acute exacerbations of chronic obstructive pulmonary disease. (François Maltais, 2001) A safe and effective therapy for young children with inhaled steroid-dependent, persistent asthma. (G Shapiro, 1998) A promising candidate for young children who are unable to utilize other available delivery devices. (M V White, 1999) An efficacious compound in populations with moderate to severe asthma. (O'Connell, 2002) Provides a better overall health status and asthma management as compared with nebulized cromolyn sodium. (Kevin R Murphy, 2003) More effective than nebulized cromolyn sodium in young children with persistent asthma. (Jeffrey G Leflein, 2002)